Legg-Calve´-Perthes disease and risks for cardiovascular diseases and blood diseases by Hailer, Y.D. et al.
Legg-Calve´-Perthes Disease and Risks for 
Cardiovascular Diseases and Blood Diseases 
WHAT’S KNOWN ON THIS SUBJECT: The pathogenesis of LCPD is 
not completely understood, but there are indications of 
pathologic changes in vascular development or function. It has 
been hypothesized that a problem in the circulation in the 
femoral head is involved. 
WHAT THIS STUDY ADDS: The study shows that patients with 
LCPD had higher risks of cardiovascular diseases and some 
diseases of the blood. These associations are consistent with 
vascular pathologic conditions and other sources of insufﬁcient 
blood supply to the femoral head. 
abstract 
OBJECTIVE: We hypothesized that patients with Legg-Calve´-Perthes 
disease (LCPD) might have higher risks of cardiovascular and blood 
diseases. 
METHODS: A total of 3141 patients, 2 to 15 years of age, with LCPD 
diagnosed between 1965 and 2005 were identiﬁed with the Swedish 
Inpatient Register. A total of 15 595 individuals without LCPD were se­
lected randomly from among the Swedish general population, with 
matching according to year of birth, age, gender, and region of resi­
dence. Cox proportional-hazard regression analyses, with adjustment 
for socioeconomic index, were used to estimate relative risks. The 
patients also were compared with their same-gender siblings. 
RESULTS: Patients with LCPD had a hazard ratio (HR) of 1.70 (95% 
conﬁdence interval [CI]: 1.39 –2.09) for cardiovascular diseases, com­
pared with individuals without LCPD. The point estimate was slightly 
higher among subjects >30 years of age at the follow-up (HR: 2.10 [95% 
CI: 1.52–2.91]). There were statistically signiﬁcantly higher risks for 
blood diseases, including anemias and coagulation defects (HR: 1.41 
[95% CI: 1.07–1.86]), which were more pronounced among subjects 
>30 years of age at the follow-up (HR: 2.70 [95% CI: 1.50 –4.84]). Pa­
tients also had statistically signiﬁcantly higher risks of hypertensive 
disease (HR: 2.97 [95% CI: 1.87–4.72]) and nutritional anemia (HR: 2.92 
[95% CI: 1.58–5.40]). Analyses using siblings as the comparison group 
showed consistent results for cardiovascular diseases. 
CONCLUSION: The results are consistent with the hypothesis that an 
insufﬁcient blood supply to the femoral head, attributable to vascular 
pathologic conditions, is involved in the pathogenesis of LCPD. 
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Legg-Calve´-Perthes disease (LCPD) in­
volves is an osteonecrosis of the fem­
oral head epiphysis and usually is di­
agnosed among children <15 years of 
age, with a peak for onset between 5 
and 8 years of age. The disease is 4 
times more common among boys, and 
there is bilateral involvement in 8% to 
24% of cases.1–3 The reported annual 
incidence varies between 0.45 cases 
per 100 000 among black children in 
South Africa,4 0.9 cases per 100 000 
among children in Japan,5 and 21 
cases per 100 000 among children in 
Liverpool, England.6 In Uppsala, Swe­
den, the annual incidence was iden­
tiﬁed as 8.5 cases per 100 000 among 
children 0 to 14 years of age in 1978 – 
1989.7 
The cause and underlying pathophysi­
ologic features of LCPD are not com­
pletely understood, but indications of 
an underlying mechanism are pro­
vided by associations with maternal 
smoking during pregnancy, small stat­
ure, skeletal retardation, and low birth 
weight.8–13 These observations are con­
sistent with inﬂuences on early growth 
that may be relevant to vascular devel­
opment or function. It has been hypoth­
esized that a circulation problem in the 
femoral head, such as venous stasis 
attributable to increased intraarticu­
lar and intraosseous pressure,14,15 
may be etiologically relevant. It has 
been suggested that anatomic abnor­
malities resulting in decreased num­
bers or capacity of blood vessels may 
increase LCPD risk.16–19 Disorders of 
the blood and blood-forming organs 
also might play a part, such as throm­
boembolic events resulting from 
changes in the coagulation system. 
Factor V Leiden mutations,20 high levels 
of anticardiolipin antibodies,21 and de­
creased levels of C and S proteins22,23 
have been reported for patients with 
LCPD, but the ﬁndings are inconsis­
tent.24 Therefore, it is possible that 
there are shared risks for LCPD and 
some cardiovascular diseases and dis­
eases of the blood and blood-forming 
organs. These shared risks might op­
erate through inheritance or exposure 
to some environmental factors in early 
life. 
In this general population–based 
study, we used Swedish registry data 
to examine the hypothesis that pa­
tients with LCPD would have a higher 
risk of cardiovascular diseases, con­
sistent with the hypothesis that vari­
ous abnormalities of the circulation 
may contribute to the pathogenesis of 
LCPD by interfering with the blood sup­
ply to the femoral head. Associations 
with diseases of the blood and blood-
forming organs also were examined, 
because these might be relevant 
through mechanisms such as ab­
normalities of coagulation predis­
posing patients to thrombophilia and 
hemorrhage. 
METHODS 
Swedish registry data were used to 
identify a cohort of patients with a di­
agnosis of LCPD. This cohort was com­
pared with a general population– 
based cohort without LCPD to assess 
the risk of cardiovascular diseases (in­
cluding hypertensive diseases, isch­
emic heart diseases, pulmonary heart 
diseases and diseases of the pulmo­
nary circulation, cerebrovascular dis­
eases, diseases of arteries, arterioles, 
and capillaries, and diseases of veins, 
lymphatic vessels, and lymph nodes, 
equivalent to International Classiﬁca­
tion of Diseases, 10th Revision, codes 
I00–I99), as well as diseases of the 
blood and blood-forming organs (in­
cluding nutritional, hemolytic, and 
aplastic anemias, coagulation defects, 
purpura, and other hemorrhagic con­
ditions, equivalent to International 
Classiﬁcation of Diseases, 10th Revi­
sion, codes D50–D89). A comparison 
cohort of siblings of patients with LCPD 
also was used. Registry data linkage 
was possible through the use of the 
unique personal registration numbers 
issued to all Swedish residents. 
The Swedish Inpatient Register in­
cludes data on individual hospital ad­
missions and was used to identify 3144 
patients with International Classiﬁca­
tion of Diseases codes for LCPD (Inter­
national Classiﬁcation of Diseases, 
Seventh Revision, codes 732.03 and 
732.04; International Classiﬁcation 
of Diseases, Eighth Revision, codes 
722.10, 722.11, and 722.19; Interna­
tional Classiﬁcation of Diseases, Ninth 
Revision, code 732B; and Interna­
tional Classiﬁcation of Diseases, 10th 
Revision, codes M91.1, M91.2, and 
M91.3),25,26 diagnosed between 1965 
and 2005. Only patients with a ﬁrst ad­
mission between 2 and 15 years of age 
were included, because this is the typ­
ical age of onset and inclusion of pa­
tients with later onset might identify 
atypical disease.27,28 
Subjects with LCPD were matched indi­
vidually with up to 5 members of the 
Swedish general population who did 
not have the disease. The matching cri­
teria were date of birth, region of 
residence (county), and gender. The 
matched individuals had to be alive at 
the time the patient received the diag­
nosis of LCPD. We were not able to ﬁnd 
matching individuals for 3 patients, 
and they were excluded. In total, we 
included 3141 patients with LCPD and 
15 595 individuals without the disease 
in the study. 
Administrative registries were used to 
identify information on dates of birth, 
death, immigration, and emigration, to 
calculate the follow-up period avail­
able for each individual. Census data 
were used to create a 6-category so­
cioeconomic index on the basis of par­
ents’ occupations (manual workers, 
nonmanual workers, professionals, 
self-employed workers, farmers, and 
others). The Swedish Multi-Generation 
Register identiﬁes ﬁrst-degree rela-
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tives29 and was used to identify sib­
lings of the study subjects. We used 
only same-gender siblings of the pa­
tients with LCPD; when there were 22 
siblings, we used the sibling with the 
smallest age difference. This yielded 
data on 2169 same-gender siblings. 
There were 973 same-gender younger 
siblings, 1165 same-gender older sib­
lings, and 31 twins. The study was 
approved by the research ethics 
committee of the Karolinska Institute 
(Stockholm, Sweden) and complied 
with the Declaration of Helsinki. 
Cox proportional-hazard regression 
analysis was used to estimate the risk 
of cardiovascular diseases; the cohort 
of patients with LCPD was compared 
with the cohort without LCPD. Sepa­
rate models examined diseases of 
the blood and blood-forming organs. 
Follow-up monitoring was from 1964, 
when the Inpatient Register was estab­
lished, or from birth or immigration if 
this occurred subsequently. Follow-up 
monitoring continued until diagnosis 
of cardiovascular diseases or dis­
eases of the blood and blood-forming 
organs, death, emigration, or Decem­
ber 31, 2005. Each person could have 
more than 1 study end point (different 
disease outcomes). The underlying 
time scale for all models was attained 
age. The analyses were both unad­
justed and adjusted for socioeconomic 
index. All models were internally strat­
iﬁed according to risk set. Events that 
occurred within 5 years after LCPD di­
agnosis were excluded for assessment 
of potential surveillance bias. Analyses 
also were stratiﬁed according to gen­
der, age at ﬁnal follow-up point (:30 
years or >30 years), and temporal se­
quence of LCPD and cardiovascular 
disease (which disease occurred 
ﬁrst). 
In supplemental analyses, we exam­
ined the following speciﬁc diseases by 
using Cox regression analyses: hyper­
tension, ischemic heart diseases, pul-
TABLE 1 Characteristics of Study Subjects 
Individuals Individuals
 
With LCPD Without
 
LCPD
 
N 3141 15 595 
Male, n (%) 2324 (74) 11 540 (74) 
Age at diagnosis/entry 
2.0–5.9 y, n (%) 646 (20.6) 3229 (20.7) 
6.0–8.9 y, n (%) 1081 (34.4) 5351 (34.3) 
9.0–11.9 y, n (%) 662 (21.1) 3302 (21.2) 
12.0–15.0 y, n (%) 752 (23.9) 3713 (23.8) 
Mean : SD, y 9.0 : 3.2 9.0 : 3.3 
Age at exit, mean : 28.3 : 10.4 28.4 : 10.3 
SD, y 
Socioeconomic index, 
n (%) 
Manual workers 1272 (40.5) 5224 (33.5) 
Nonmanual 675 (21.5) 3587 (23.0) 
workers 
Professionals 324 (9.5) 2074 (13.3) 
Farmers 75 (2.2) 343 (2.2) 
Self-employed 191 (6.1) 842 (5.4) 
workers 
Others 638 (20.3) 3524 (22.6) 
monary heart diseases and diseases 
of the pulmonary circulation, cerebro­
vascular diseases, diseases of veins, 
lymphatic vessels, and lymph nodes, 
coagulation defects, nutritional ane­
mia, and hemolytic anemia. As an addi­
tional comparison group, we used 
same-gender siblings of the patients 
with LCPD with the smallest age differ­
ence. The siblings without a diagnosis 
of LCPD who were closest in age to the 
index subjects were selected. The risk 
of cardiovascular diseases and dis­
eases of the blood and blood-forming 
organs was assessed when patients 
with LCPD were compared with their 
siblings. We also performed analyses 
with data restricted to younger or 
older siblings. All statistical analyses 
were performed by using SAS 9.1 (SAS 
Institute, Cary, NC). 
RESULTS 
Study Groups 
The mean age of the 3141 patients at 
diagnosis was 9 years (median: 8.6 
years), with a peak between ages 6 and 
8 years (Table 1). The mean age at the 
end of the follow-up period for both in­
dividuals with LCPD and individuals 
without LCPD was 28 years (median: 31 
years), with a range of 2 to 55 years. In 
total, 12% of the study subjects were 
240 years of age at the ﬁnal follow-up 
point, but <1% were 50 to 55 years of 
age and the exposed and unexposed 
cohorts were equivalent. In total, 74% 
of the subjects were male. 
Cardiovascular Diseases 
Patients with LCPD had a 70% higher 
risk of cardiovascular diseases, com­
pared with gender- and age-matched 
individuals without LCPD (Table 2), 
which yielded a statistically signiﬁcant 
hazard ratio (HR) of 1.70 (95% conﬁ­
dence interval [CI]: 1.39–2.09). Adjust­
ment for socioeconomic index did not 
change the results notably. Of all car­
diovascular diseases, the risks of hy­
pertensive diseases (HR: 2.97 [95% CI: 
1.87– 4.72]), ischemic heart diseases 
(HR: 2.69 [95% CI: 1.20 –6.03]), and dis­
eases of veins, lymphatic vessels, and 
lymph nodes (HR: 1.93 [95% CI: 1.29 – 
2.90]) among patients with LCPD were 
higher and statistically signiﬁcant. Ex­
clusion of events that occurred in the 5 
years after LCPD diagnosis did not 
change the estimate notably (HR: 1.67 
[95% CI: 1.35–2.07]). Analyses strati­
ﬁed according to the temporal se­
quence of LCPD and cardiovascular 
diseases revealed a HR of 3.28 (95% CI: 
1.68–6.41) for cardiovascular dis­
eases diagnosed before LCPD and a HR 
of 1.58 (95% CI: 1.27–1.96) for cardio­
vascular diseases diagnosed after 
LCPD. Analyses stratiﬁed according to 
age at the end of the follow-up period 
showed that the HRs for subjects :30 
and >30 years of age were 1.60 (95% 
CI: 1.08–2.35) and 2.10 (95% CI: 1.52– 
2.91), respectively. Stratiﬁcation ac­
cording to gender and age at the end of 
the follow-up period (:30 or >30 
years of age) did not change the point 
estimates notably (data not shown). 
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TABLE 2 Associations Between LCPD and Cardiovascular Diseases and Diseases of Blood and 
Blood-Forming Organs 
Diseases (ICD-9 Codes) n (%) HR (95% CI) 
Individuals Individuals Unadjusted Adjusted for 
With LCPD Without LCPD Socioeconomic 
Index 
Cardiovascular diseases (390–459) 
No 3012 (95.9) 15 221 (97.6) Reference Reference 
Yes 129 (4.1) 374 (2.4) 1.70 (1.38–2.08) 1.70 (1.39–2.09) 
Hypertensive diseases (401–405) 
No 3110 (99.0) 15 545 (99.7) Reference Reference 
Yes 31 (1) 50 (0.3) 3.00 (1.90–4.70) 2.97 (1.87–4.72) 
Ischemic heart diseases (410–414) 
No 3131 (99.7) 15 577 (99.9) Reference Reference 
Yes 10 (0.3) 18 (0.1) 2.50 (1.15–5.46) 2.69 (1.20–6.03) 
Pulmonary heart diseases and 
diseases of pulmonary 
circulation (415–417) 
No 3136 (99.8) 15 577 (99.9) Reference Reference 
Yes 5 (0.2) 18 (0.1) 1.34 (0.50–3.65) 1.04 (0.37–2.94) 
Cerebrovascular diseases (430–438) 
No 3132 (99.7) 15 565 (99.8) Reference Reference 
Yes 9 (0.3) 30 (0.2) 1.39 (0.63–3.06) 1.36 (0.60–3.06) 
Diseases of arteries, arterioles, and 
capillaries (440–448) 
No 3136 (99.8) 15 583 (99.9) Reference Reference 
Yes 5 (0.2) 12 (0.1) 2.22 (0.76–6.45) 2.15 (0.70–6.56) 
Diseases of veins, lymphatic vessels, 
and lymph nodes (451–459) 
No 3107 (98.9) 15 507 (99.4) Reference Reference 
Yes 34 (1.1) 88 (0.6) 1.87 (1.25–2.78) 1.93 (1.29–2.90) 
Diseases of blood and blood-forming 
organs (280–289) 
No 3074 (97.9) 15 354 (98.5) Reference Reference 
Yes 67 (2.1) 241 (1.6) 1.44 (1.10–1.90) 1.41 (1.07–1.86) 
Coagulation defects (286–287) 
No 3123 (99.4) 15 530 (99.6) Reference Reference 
Yes 18 (0.6) 65 (0.4) 1.49 (0.88–2.52) 1.49 (0.87–2.54) 
Nutritional anemia (280–281) 
No 3124 (99.5) 15 565 (99.8) Reference Reference 
Yes 17 (0.5) 30 (0.2) 2.86 (1.57–5.21) 2.92 (1.58–5.40) 
Hemolytic anemia (282–285) 
No 3125 (99.5) 15 544 (99.7) Reference Reference 
Yes 16 (0.5) 51 (0.3) 1.73 (0.97–3.08) 1.62 (0.90–2.92) 
ICD-9 indicates International Classiﬁcation of Diseases, Ninth Revision. 
age at the ﬁnal follow-up visit (:30 
or >30 years of age) revealed that, 
whereas risk was increased among pa­
tients >30 years of age at the follow-up 
visit (HR: 2.70 [95% CI: 1.50 –4.84]), pa­
tients with LCPD who were :30 years of 
age at the follow-up visit did not have any 
signiﬁcant risk (HR: 0.89 [95% CI: 0.54– 
1.46]). 
The analyses for more-speciﬁc out­
comes revealed statistically signiﬁcantly 
increased risk of nutritional anemia 
among patients with LCPD (HR: 2.92 [95% 
CI: 1.58–5.40]). The increased risks of he­
molytic anemia and coagulation defects 
were not statistically signiﬁcant. When 
we estimated the risks of coagulation de­
fects with disposition to thrombosis (ie, 
protein C deﬁciency),30 we observed a HR 
of 5.74, although with a wide CI (95% CI: 
0.85–38.80) because of sparse data. The 
risk estimate for a coagulation defect 
with disposition to hemorrhage (ie, de­
creased von Willebrand factor levels) 
was 1.31 (95% CI: 0.74–2.34) and not sta­
tistically signiﬁcant. 
Siblings as Comparison Cohort 
Patients with LCPD had a 40% greater 
risk of cardiovascular diseases, com­
pared with their same-gender siblings 
(Table 3), but this was not statisti­
cally signiﬁcant (HR: 1.42 [95% CI: 
0.99 –2.04]). When the patients were 
compared with their younger siblings 
and older siblings, separately, the 
same patterns of increased risk for 
cardiovascular diseases were ob­
served in both analyses. The risk for 
diseases of the blood and blood-
forming organs of the patients, com­
pared with their siblings, was close to 
unity, and stratiﬁcation for younger 
and older siblings did not result in a 
statistically signiﬁcant association. 
DISCUSSION 
This general population–based study 
found that LCPD was associated with 
greater risk of cardiovascular dis-
Diseases of Blood and Blood-
Forming Organs 
Patients with LCPD had a 40% higher risk 
of diseases of the blood and blood-
forming organs, including nutritional, 
hemolytic, and aplastic anemias, coagu­
lation defects, purpura, and other hem­
orrhagic conditions (Table 2), compared 
with individuals without LCPD (HR: 1.41 
[95% CI: 1.07–1.86]). Adjustment for so­
cioeconomic index did not change the re­
sults notably, and neither did exclusion 
of events 5 years after LCPD diagnosis 
(HR: 1.40 [95% CI: 1.06–1.84]). Analyses 
stratiﬁed according to the temporal se­
quence of LCPD and diseases of the blood 
and blood-forming organs yielded a HR 
of 1.03 (95% CI: 0.53–1.99) for diseases of 
the blood and blood-forming organs di­
agnosed before LCPD and a HR of 1.51 
(95% CI: 1.11–2.04) for diseases of the 
blood and blood-forming organs diag­
nosed after LCPD. Analyses stratiﬁed ac­
cording to gender did not change the 
point estimates substantially (data not 
shown). Analysis stratiﬁed according to 
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eases and diseases of the blood and 
blood-forming organs. Speciﬁc risks 
were for hypertensive diseases, isch­
emic heart diseases, and diseases of 
the veins, lymphatic vessels, and 
lymph nodes. These ﬁndings provide 
more evidence of cardiovascular in­
volvement in the pathogenesis of 
LCPD. This supports our hypothesis 
that cardiovascular diseases would 
be observed more frequently among 
patients with LCPD, because these 
diseases share some common risks 
through inheritance or exposure. 
The increase in cardiovascular dis­
ease risk among patients with LCPD is 
consistent with previous laboratory 
and experimental ﬁndings. Hresko et 
al31 found higher levels of lipopro­
tein(a), which is well-established risk 
factor for cardiovascular diseas­
es,32,33 in children with LCPD. In an 
experimental study, Hirano et al34 in­
duced LCPD in spontaneously hyper­
tensive rats. This indicates that an 
ischemic vascular insult can lead to 
typical osteonecrosis of the growing 
femoral head in rats, resembling 
LCPD in children. 
More evidence for the possible role 
of vascular abnormalities in the 
pathogenesis of LCPD comes from 
identiﬁcation of common risks for 
LCPD and cardiovascular diseases, 
weight.11,12,35,36including low birth 
Maternal smoking during pregnancy 
has been implicated in the pathogen­
esis of atherosclerosis,37,38 hyperten­
sion among children,39 and LCPD.11
However, angiographic and veno­
graphic studies did not ﬁnd any ra­
diologically visible pathologic fea­
tures in the femoral head vessels of 
patients with LCPD.16,40,41 We did not 
identify any published histologic 
studies of vascular pathologic condi­
tions associated with LCPD. The 
threefold higher risk for nutritional 
anemia in patients with LCPD is con­
sistent with the results of an experi-
TABLE 3	 Risks of Cardiovascular Diseases and Diseases of Blood and Blood-Forming Organs 
Among Patients With LCPD, in Comparison With Same-Gender Siblings 
No. of Events HR (95% CI) 
Patients and siblings with smallest age difference 
Cardiovascular diseases 
Siblings 69 Reference 
Patients 87 1.42 (0.99–2.04) 
Diseases of blood and blood-forming organs 
Siblings 50 Reference 
Patients 44 0.88 (0.57–1.37) 
Patients and younger siblings 
Cardiovascular diseases 
Siblings 16 Reference 
Patients 35 1.40 (0.72–2.72) 
Diseases of blood and blood-forming organs 
Siblings 16 Reference 
Patients 35 0.72 (0.35–1.47) 
Patients and older siblings 
Cardiovascular diseases 
Siblings 53 Reference 
Patients 51 1.40 (0.91–2.16) 
Diseases of blood and blood-forming organs 
Siblings 53 Reference 
Patients 51 1.00 (0.57–1.76) 
mental study in which changes in 
femoral head growth in experimen­
tally induced chronic anemia in rab­
bits were observed.42 Higher risk for 
LCPD in patients with sickle cell ane­
mia or thalassemia also was report­
ed.23,43–46 Our ﬁnding of an increased 
risk for hemolytic anemia provides 
additional evidence of a role for ane­
mia, although the association was 
not statistically signiﬁcant. 
We observed an elevated risk of coag­
ulation defects, especially coagulation 
disorders with disposition to thrombo­
sis, such as thrombophilia, activated 
protein C resistance, and antiphos­
pholipid antibody syndrome, al­
though ﬁndings were based on few 
cases and were not statistically signif­
icant; however, the ﬁndings are consis­
tent with our hypothesis. Patients with 
LCPD have lower protein C levels, resis­
tance to protein C, or protein S deﬁ­
ciency.22,47,48 It also has been reported 
that these patients might have coagu­
lation abnormalities such as muta­
tions in the factor V gene (Leiden), 
higher levels of anticardiolipin antibod­
ies, or hereditary thrombophilia,21,22,48–50 
although results are inconsis­
tent.24,31,51–53 Overall, the previous ﬁnd­
ings and our results are consistent 
with the hypothesis that various ab­
normalities of the circulation may con­
tribute to the pathogenesis of LCPD by 
interfering with the blood supply to the 
femoral head. 
We used same-gender siblings of pa­
tients with LCPD with the smallest age 
difference as an additional compari­
son group. The potential advantage of 
using this comparison group is that 
the close matching for some familial 
characteristics further reduces the 
risk of confounding. We observed sim­
ilar risk patterns of higher cardiovas­
cular disease risk among patients with 
LCPD than their siblings, although this 
was not statistically signiﬁcant. The 
ﬁndings for diseases of the blood and 
blood-forming organs were less con­
sistent, which possibly reﬂects etio­
logic heterogeneity. It should be noted 
that the statistical power for compari­
sons with siblings was much reduced 
because of smaller numbers, which in­
ﬂuenced statistical signiﬁcance. The 
closer matching of siblings as a com­
parison group might reduce the 
magnitude of associations; genetic 
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inheritance and early-life risks for car­
diovascular diseases are shared more 
often between siblings than with an 
unrelated comparator. 
This is one of the ﬁrst studies to inves­
tigate whether patients with LCPD have 
greater risks for diseases of vascular 
origin, compared with a general popu­
lation comparison group, with a 
large sample size and relatively long 
follow-up time. Because the onset of 
many cardiovascular diseases is in 
later life, as conﬁrmed by the greater-
magnitude estimates of association 
with LCPD found when we examined 
subjects >30 years of age, our study 
might have produced conservative es­
timates, because the majority of sub­
jects were still relatively young. Conse­
quently, the numbers of events were 
small, and we used disease groups 
rather than speciﬁc diseases for the 
main analysis. 
Our hypothesis of common risks for 
LCPD and cardiovascular diseases al­
lows for either temporal sequence of 
disease diagnosis; it does not matter 
which disease occurs ﬁrst. Because 
cardiovascular diseases predated 
LCPD in some cases, reduced physical 
exercise attributable to LCPD increas­
ing the risk for cardiovascular dis­
eases is unlikely to be the sole expla-
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Hailer et al. Legg-Calvé-Perthes Disease and Risks for Cardiovascular 
Diseases and Blood Diseases. Pediatrics. 2010;125(6):e1308–e1315 
An error occurred in this article by Hailer et al, titled “Legg-Calvé-Perthes Disease 
and Risks for Cardiovascular Diseases and Blood Diseases” published in the June 
2010 issue of Pediatrics (2010;125[6]:e1308–e1315; originally published online 
May 3, 2010; doi:10.1542/peds.2009–2935). 
The ICD codes that we used to identify a diagnosis of Legg-Calvé-Perthes disease 
(LCPD) included some non-speciﬁc codes that may have included other di­
agnoses. We therefore reanalyzed the data by using only ICD codes speciﬁc to  
LCPD (ICD-7 code 732.04; ICD-8 code 722.11; ICD-9 code 732B; and ICD-10 codes 
M91.1, M91.2). The corrected abstract and tables follow. 
abstract 
OBJECTIVE: We hypothesized that patients with Legg-Calvé-Perthes disease (LCPD) 
might have higher risks of cardiovascular and blood diseases. 
METHODS: A total of 2579 patients with LCPD diagnosed between 1965 and 2005 
were identiﬁed with the Swedish Inpatient Register. A total of 13 748 individuals 
without LCPD were selected randomly from among the Swedish general popula­
tion, with matching according to year of birth, age, gender, and region of resi­
dence. Cox proportional-hazard regression analyses, with adjustment for 
socioeconomic index, were used to estimate relative risks. The patients also 
were compared with their same-gender siblings. 
RESULTS: Patients with LCPD had a hazard ratio (HR) of 1.70 (95% conﬁdence in­
terval [CI]: 1.48–1.95) for cardiovascular diseases, compared with individuals 
without LCPD. There were statistically signiﬁcantly higher risks for hypertensive 
disease, ischemic heart diseases, cerebrovascular diseases, and diseases of 
arteries, veins, and lymphatic vessels. There were statistically signiﬁcantly higher 
risks for blood diseases, including anemias and coagulation defects (HR: 1.94 
[95% CI: 1.51–2.49]), which were more pronounced among subjects .30 years of 
age at the follow-up (HR: 2.45 [95% CI: 1.77–3.41]). Patients also had statistically 
signiﬁcantly higher risks of nutritional anemia (HR: 2.32 [95% CI: 1.41–3.81]) and 
hemolytic anemia (HR: 2.59 [95% CI: 1.72–3.92]). Analyses using siblings as the 
comparison group showed consistent results for cardiovascular diseases. 
CONCLUSIONS: The results are consistent with the hypothesis that an insufﬁcient 
blood supply to the femoral head, attributable to vascular pathologic conditions, is 
involved in the pathogenesis of LCPD. Pediatrics 2013;132:186–187 
doi:10.1542/peds.2013-0972 
TABLE 1 Characteristics of the Study Subjects 
Individuals With LCPD Individuals Without LCPD 
Total number 2579 13 748 
Male (%) 1936 (75.1) 10 408 (75.7) 
Socioeconomic index 
Manual workers 890 (34.5) 3940 (28.7) 
Non-manual workers 460 (17.8) 2579 (18.8) 
Professionals 204 (7.9) 1548 (11.3) 
Farmers 29 (1.1) 263 (1.9) 
Self-employed workers 133 (5.2) 623 (4.5) 
Others 863 (33.5) 4795 (34.9) 
ERRATA 
  
186 ERRATA 
ERRATA
TABLE 2 Association Between Legg-Calvé-Perthes Disease 
2579 Individuals With LCPD (75.1% Male) and 13 
(LCPD) and Cardiovascular Diseases 
748 Individuals Without LCPD (75.7% 
and Diseases 
Male) 
of the Blood and Blood-Forming Organs, 
Disease (ICD-9 Code) Individuals With 
LCPD, % 
Individuals 
LCPD, 
Without 
% 
Hazard Ratio (95% Conﬁdence Interval) 
Unadjusted Adjusted for 
Socioeconomic Index 
Cardiovascular diseases (390–459) 
No 
Yes 
Hypertensive diseases (401–405) 
No 
Yes 
Ischemic heart diseases (410–414) 
No 
Yes 
Pulmonary heart disease and diseases of pulmonary circulation (415–417) 
No 
Yes 
Cerebrovascular diseases (430–438) 
No 
Yes 
Diseases of arteries, arterioles, and capillaries (440–448) 
No 
Yes 
Diseases of veins, lymphatic vessels, and lymph nodes (451–459) 
No 
Yes 
Diseases of the blood and blood-forming organs (280–289) 
No 
Yes 
Coagulation defects (286–287) 
No 
Yes 
Nutritional anemia (280–281) 
No 
Yes 
Hemolytic anemia (282–285) 
No 
Yes 
88.4 
11.6 
96.2 
3.8 
96.5 
3.5 
99.5 
0.5 
96.9 
3.1 
98.5 
1.5 
97.2 
2.8 
96.5 
3.5 
99.5 
0.5 
99.1 
0.9 
98.6 
1.4 
91.8 
8.2 
97.9 
2.1 
97.3 
2.7 
99.6 
0.4 
98.0 
2.0 
99.0 
1.0 
98.2 
1.8 
98.0 
2.0 
99.6 
0.4 
99.5 
0.5 
99.3 
0.7 
Reference 
1.70 (1.47–1.94) 
Reference 
2.21 (1.72–2.84) 
Reference 
1.60 (1.25–2.06) 
Reference 
1.48 (0.80–2.71) 
Reference 
1.76 (1.34–2.31) 
Reference 
1.92 (1.30–2.83) 
Reference 
1.71 (1.30–2.24) 
Reference 
1.96 (1.53–2.52) 
Reference 
1.30 (0.72–2.36) 
Reference 
2.24 (1.37–3.66) 
Reference 
2.60 (1.73–3.92) 
Reference 
1.70 (1.48–1.95) 
Reference 
2.19 (1.70–2.81) 
Reference 
1.59 (1.24–2.05) 
Reference 
1.25 (0.67–2.33) 
Reference 
1.79 (1.36–2.36) 
Reference 
1.91 (1.29–2.82) 
Reference 
1.73 (1.31–2.28) 
Reference 
1.94 (1.51–2.49) 
Reference 
1.26 (0.69–2.29) 
Reference 
2.32 (1.41–3.81) 
Reference 
2.59 (1.72–3.92) 
TABLE 3 Risks of Cardiovascular 
Gender Siblings 
Diseases and Diseases of Blood and Blood-Forming Organs Among Patients With LCPD, in Comparison With Same-
Events Hazard Ratio (95% CI) 
Patients and siblings with the least age difference (n 
Cardiovascular diseases 
Siblings 
Patients 
Diseases of the blood and blood-forming organs 
Siblings 
Patients 
Patients and younger siblings (n 5 721) 
Cardiovascular diseases 
Siblings 
Patients 
Diseases of the blood and blood-forming organs 
Siblings 
Patients 
Patients and older siblings (n 5 831) 
Cardiovascular diseases 
Siblings 
Patients 
Diseases of the blood and blood-forming organs 
Siblings 
Patients 
5 1552) 
58 
98 
31 
41 
26 
47 
12 
16 
32 
50 
19 
25 
Reference 
2.28 (1.49–3.21) 
Reference 
1.59 (0.93–2.71) 
Reference 
1.57 (0.91–2.72) 
Reference 
1.10 (0.47–2.59) 
Reference 
2.88 (1.66–5.00) 
Reference 
2.00 (1.00–4.00) 
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